ArThec is a medical biotechnology company specializing in tissue engineering and regenerative medicine. We focus on developing Advanced Therapy Medicinal Products (ATMPs) and innovative medical devices that support our transformative therapies. At the heart of our approach is Pearl Technology, a proprietary, cutting-edge platform designed to regenerate damaged cartilage and restore joint function.
The Pearl procedure enables the complete regeneration of cartilage, offering a durable, long-term solution for joint degeneration. By harnessing the power of advanced tissue engineering, we help patients maintain their natural, fully functional joints for a lifetime, reducing the need for invasive surgeries and improving quality of life.
Company Details
- Employees
- 5
- Founded
- 2019
- Address
- Starodworska, 1,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://arthec.eu
- HQ
- Gdańsk
Arthec S.a. Questions
Arthec S.A.'s website is http://arthec.eu
Arthec S.A.'s LinkedIn profile is https://pl.linkedin.com/company/arthec-sa
Arthec S.A. has
5 employees.
View email and phone details for 5
employees at Arthec S.A..
Arthec S.A.'s industry is
Biotechnology Research
Arthec S.A.'s top competitors are
Leciforce,
Śmietański Hernia Center | Centrum Leczenia Przepuklin Prof. Śmietańskiego,
Urteste,
Centrum Edukacji Medycznej Cem,
Olympus Polska Sp Z O O,
Wavejo,
Biotech Ortopedia,
Selvita,
Bio-Chic,
Mabion S.a..
Arthec S.A.'s categories are Biotechnology Research
Arthec S.A.'s founding year is 2019
